Normal cells, including fibroblasts, show density-dependent growth and form monolayers in culture. 1) This is quite different from cell behavior in vivo, where the cells are multilayered and surrounded by extracellular matrix (ECM) components, such as collagen and proteoglycan produced by the cells themselves. The active role of ECM in cell attachment, proliferation 2) and differentiation 3) has recently been recognized. Artificial collagen gels 4) and insoluble ECM 5) obtained from various tissues have been used in studies on cell growth and differentiation. Type I collagen is a major structural protein and is found in large quantities in various parts of the body, especially in the skin, bones, teeth and tendons. A decrease in the production of type I collagen, or that of defective molecules, induces organ deformity or dysfunction and retards embryo and fetus development in extreme cases. [6] [7] [8] On the other hand, aberrant accumulation of type I collagen in tissues and organs results in organ fibrosis, such as in progressive systemic sclerosis (scleroderma) of the skin, liver fibrosis and pulmonary fibrosis, and also occasionally endangers the life of affected individuals. 7, 8) L-Ascorbic acid (vitamin C) is known to be a neutral bioactive agent, and its multifarious activities in many biological systems have been reported. For example, vitamin C increases enzyme activity [9] [10] [11] ; acts as an inducer of the collagen pathway 12) ; and scavenges free radicals as an antioxidant during oxidant stress. 13, 14) An essential function of vitamin C is to act as a cofactor for the hydroxylation of proline and lysine residues in collagen, a major protein component of the body. Vitamin C also increases the transcription rate of procollagen genes and stabilizes procollagen mRNA. 15, 16) Its ability to cure scurvy is possibly due to stimulation of collagen synthesis in connective tissues.
Normal cells, including fibroblasts, show density-dependent growth and form monolayers in culture. 1) This is quite different from cell behavior in vivo, where the cells are multilayered and surrounded by extracellular matrix (ECM) components, such as collagen and proteoglycan produced by the cells themselves. The active role of ECM in cell attachment, proliferation 2) and differentiation 3) has recently been recognized. Artificial collagen gels 4) and insoluble ECM 5) obtained from various tissues have been used in studies on cell growth and differentiation. Type I collagen is a major structural protein and is found in large quantities in various parts of the body, especially in the skin, bones, teeth and tendons. A decrease in the production of type I collagen, or that of defective molecules, induces organ deformity or dysfunction and retards embryo and fetus development in extreme cases. [6] [7] [8] On the other hand, aberrant accumulation of type I collagen in tissues and organs results in organ fibrosis, such as in progressive systemic sclerosis (scleroderma) of the skin, liver fibrosis and pulmonary fibrosis, and also occasionally endangers the life of affected individuals. 7, 8) L-Ascorbic acid (vitamin C) is known to be a neutral bioactive agent, and its multifarious activities in many biological systems have been reported. For example, vitamin C increases enzyme activity [9] [10] [11] ; acts as an inducer of the collagen pathway 12) ; and scavenges free radicals as an antioxidant during oxidant stress. 13, 14) An essential function of vitamin C is to act as a cofactor for the hydroxylation of proline and lysine residues in collagen, a major protein component of the body. Vitamin C also increases the transcription rate of procollagen genes and stabilizes procollagen mRNA. 15, 16) Its ability to cure scurvy is possibly due to stimulation of collagen synthesis in connective tissues. 17) However, vitamin C is unstable in aqueous solutions, even under normal culture conditions at neutral pH and 37°C. To solve this problem, a number of stable derivatives, including L-ascorbic acid 2-sulfate and L-ascorbic acid 2-phosphate (VCP-Na), have been developed. 18, 19) VCP-Na shows antiscorbutic activity in guinea pigs, 20, 21) and has a stimulatory effect on collagen synthesis in cultured human skin fibroblasts, 22, 23) while L-ascorbic acid 2-sulfate does not show these effects. 24) We have recently synthesized a novel lipophilic alkyl vitamin C derivative, sodium isostearyl 2-O-L-ascorbyl phosphate (VCP-IS-Na), which is characterized by its high stability in various aqueous solutions, throughout a wide range of pH values, and its non-reducibility. 25) We have also demonstrated that VCP-IS-Na is superior to VCP-Na with regard to enzymatic hydrolysis by tissue esterase and/or phosphatase to give vitamin C. These findings indicate that vitamin C, released from VCP-IS-Na by enzymatic hydrolysis, exhibits these biological activities.
Structurally, the difference between the existing vitamin C derivative VCP-Na and the novel vitamin C derivative VCP-IS-2Na, which increased stability upon exposure to alkali, oxidation, and prolonged storage more than VCP-IS-Na, is that in the 2 position the former has phosphate and the latter, isostearyl phosphate. To exclude the collagen synthesis-enhancing actions of VCP-IS-2Na and VCP-Na, we compared the activity of the hydrolases, which convert the derivatives into vitamin C. Therefore, an understanding of this is essen- tial in determining whether we can expect the pharmacological activity of vitamin C to be manifested when VCP-IS-2Na is added to cosmetic products.
Effect of a Novel
In the present study, we found that VCP-IS-2Na effectively stimulated collagen synthesis and inhibited matrix metalloproteinase-1 (MMP-1) activity, which digest collagen, gelatin and other components of the ECM, which are important for both normal development and carcinogenesis in cultured normal human skin fibroblasts. Increases in the amount of vitamin C in normal human fibroblasts and cell proliferation are also described.
MATERIALS AND METHODS
Chemicals L-Ascorbic acid was obtained from SigmaAldrich Japan K.K. (Tokyo, Japan). VCP-Na and 3-(4,5-dimethylthiazol)-2,5-diphenyl-tatrazolium bromide (MTT) were obtained from Wako Pure Chemical Industries (Osaka, Japan). Isostearyl alcohol was obtained from Nissan Chemical Industries (Tokyo, Japan). Phosphatase inhibitor cocktail II was obtained from Merck.
Procedure 1 H-and 13 C-NMR spectra (d, J in Hz) were recorded on a JEOL GSX 500 NMR spectrometer. Tetramethylsilane was used as the internal reference (d 0.00) for 1 H-NMR spectra measured in chloroform-d 1 . This solvent was also used for 13 C-NMR spectra. Infrared (IR) spectra were determined with an FT/IR-470 Pulse Fourier Transform Infrared Spectrometer using a KBr disk. Fast atom bombardment high resolution mass spectra (FAB-HR-MS) and FAB-MS spectra were obtained on a JEOL JMS-HX 100 mass spectrometer. UV spectra were obtained on a Shimadzu UV-2450 spectrophotometer. Optical rotations were measured with JASCO DIP-1000. HPLC analysis was carried out with a system consisting of a Shimadzu SCL-10AVP system controller, LC-10ADVP pump, SPD-10AVP UV-Vis spectrophotometric detector, SIL-10AVP auto-injector, CTO-10A column oven, and CLASS-VP chromatopac.
Synthesis of VCP-IS-2Na VCP-IS was synthesized from 5,6-O-isopropylidene-ascorbic acid and isostearyl dichlorophosphate by the methods described in our previous report. 25) VCP-IS (1 mol) was reacted with sodium hydrate (2 mol). The reaction mixture was stirred at 0°C for 3 h, ethanol was added, and evaporated in vacuo. The residue was subjected to recrystallization in acetonitrile and ethanol to give VCP-IS-2Na (65% yield), as a white powder. For VCP-IS-2Na: (Fig. 1) .
Cell Culture Normal human skin fibroblasts, NHDF and NB1RGB, were used. NHDF cells were purchased from Kurabo (Japan), and cultured with Kurabo's modified Medium 106S, containing 5% fetal bovine serum (FBS). NB1RGB cells were purchased from Cell Bank, RIKEN BioResource Center (Japan), and cultured with Dulbecco's modified Eagle's medium (DMEM) containing 5% FBS. Then, normal human fibroblasts (NHDF and NB1RGB) were assayed for proliferation, collagen and collagenase activity, as described below.
HPLC Conditions The separation of vitamin C was achieved by isocratic elution from an RP-18 (f 4.6ϫ250 mm, 5 mm; GL Science, Tokyo, Japan), kept at 40°C, with 0.1 M sodium acetate/acetic acid buffer (pH 5.0) containing 4% methanol, 2.8 mM n-hexylamine, and 0.01 mM disodium edetate at a flow rate of 0.7 ml/min. The spectrum absorbance at 245 nm was monitored.
Assay of Fibroblast Proliferation NHDFs or NB1RGBs were inoculated into 96-well microplates (2.0ϫ10 4 cells/well) and cultivated for 24 h. After culture, the medium was changed to serum-free medium containing VCP-IS-2Na at several concentrations, and cultivated for 72 h. Control cells were cultivated without samples. After 72 h incubation, fibroblasts were used for the MTT assay, based on the Mosmann method.
26)
Collagen Synthesis Assay NHDFs or NB1RGBs were inoculated into 96-well microplates (2.0ϫ10 4 cells/well) and cultivated for 24 h. After culture, the medium was changed to serum-free medium containing VCP-IS-2Na at several concentrations, and NHDFs or NB1RGBs were cultivated for each time. Control cells were cultivated without samples. After culture, supernatants of each well were collected, and the amount of procollagen type I pN-peptide was measured by using a type I pN-peptide assay kit (TaKaRa, Kyoto, Japan). To establish that the enhancing effect of VCP-IS-2Na on collagen synthesis is caused, not by VCP-IS-2Na, but by vitamin C, which is produced by hydrolysis with phosphatase in the fibroblasts, it was examined whether NHDFs or NB1RGBs were cultured with medium or HBS containing the phosphatase inhibitor cocktail II (PIC II ) at several concentrations.
Collagenase Synthesis Inhibition Assay NHDFs or NB1RGBs were inoculated into 96-well microplates (2.0ϫ10 4 cells/well) and cultivated for 24 h. After culture, the medium was changed to serum-free medium containing VCP-IS-2Na at several concentrations, and cultivated for 72 h. Control cells were cultivated without samples. After culture, supernatants of each well were collected, and the amount of interstitial collagenase was measured with the MMP-1 activity assay system (Amersham, Sweden). Skin Fibroblasts NHDFs or NB1RGBs were inoculated into 75 cm 2 flasks (1.0ϫ10 6 cells/flask) and cultivated for 24 h. After culture, the medium was changed to serum-free medium containing 50 mM VCP-IS-2Na, and NHDFs or NB1RGBs were cultivated for each time. Cultured NHDFs or NB1RGBs in 10 flasks after a fixed period of time were washed three times with PBS, and 1.0 ml PBS was added. The cells were scraped off with a cell scraper and transferred to an Eppendorf tube. The cell suspension (1.0ϫ10 7 cells/ml) in 0.1 M PBS was sonicated and centrifuged at 4000 r.p.m. (4°C) for 10 min, to obtain a supernatant. The supernatant was subjected to HPLC analysis. To establish whether VCP-IS-2Na produced vitamin C by hydrolysis with phosphatase in the fibroblasts, NHDFs or NB1RGBs were cultured with medium or HBS containing 0.1% PIC II.
Analysis of the Amount of Ascorbic Acid in Human

RESULTS
Effect on Fibroblast Proliferation
We investigated the effect of VCP-IS-2Na on proliferation of normal human fibroblasts, and NHDF and NB1RGB cells. VCP-IS-2Na increased the proliferation of normal human fibroblasts in a dose-dependent manner. VCP-IS-2Na (50 mM) increased proliferation of NHDF and NB1RGB cells by 123 and 135%, respectively, compared to that of untreated fibroblasts (Fig. 2) . On the other hand, vitamin C and VCP-Na slightly inhibited fibroblast proliferation.
Collagen Synthesis in Human Skin Fibroblasts Promotion of collagen synthesis was evaluated in human skin fibroblasts, NHDF and NB1RGB cells, treated with VCP-IS2Na. As shown in Fig. 3 , the amount of type I collagen in the culture medium of NHDF and NB1RGB cells was increased by treatment with VCP-IS-2Na for 72 h, in a dose-dependent manner. Compared with untreated fibroblasts, VCP-IS-2Na 50 mM increased proliferation of NHDF cells by a maximum of 116%, whereas vitamin C and VCP-Na increased proliferation by only 18 and 27%, respectively. VCP-IS-2Na 50 mM increased proliferation of NB1RGB cells by a maximum of 1067%, whereas vitamin C and VCP-Na increased proliferation by 402 and 681%, respectively. As shown in Fig. 4 , VCP-IS-2Na and VCP-Na showed a maximum increase in the collagen synthesis at 3 d, and decreased the amount of collagen synthesis thereafter in NHDF and NB1RGB cells. On the other hand, vitamin C continued to decrease the amount of collagen synthesis after 1 d in NHDF and NB1RGB cells. VCP-IS-2Na further increased type I collagen synthesis by 103 and 927% in NHDFs and NB1RGBs after only 1 d, although vitamin C and VCP-Na had little effect. We evaluated collagen synthesis in normal human fibroblasts, and NHDF and NB1RGB cells cultured with medium containing phosphatase inhibitor cocktail II (PIC II). In the presence of PIC II, the enhancing effect of VCP-IS2Na and VCP-Na on collagen synthesis was abrogated, although the effect of vitamin C was not greatly affected (Fig.  5) . In the presence of 0.1% PIC II, VCP-IS-2Na decreased collagen synthesis by 29 and 34% in NHDF and NB1RGB cells, respectively. In the presence of 0.1% PIC II, VCP-Na decreased collagen synthesis by 18 and 56% in NHDF and NB1RGB cells, respectively.
Inhibitory Effects of MMP-1 Activity in Human Skin Fibroblasts
The inhibitory activities of MMP-1 were evaluated in human skin fibroblasts NHDF and NB1RGB cells treated with VCP-IS-2Na, by measuring the production of MMP-1 in the culture medium. As shown in Fig. 6 , VCP-IS2Na had a small inhibitory effect on MMP-1, in a concentration-dependent manner. VCP-IS-2Na 50 mM inhibited MMP-1 production by a maximum of 19 and 11% in NHDF and NB1RGB cells, respectively. On the other hand, VCP-Na inhibited MMP-1 production in NHDF and NB1RGB cells by 8 and 6%, respectively, but vitamin C did not inhibit MMP-1 production in NHDF or NB1RGB cells.
Vitamin C Content in Human Skin Fibroblasts
We measured the amount of vitamin C in NHDF and NB1RGB cells treated with VCP-IS-2Na. On the first day after treatment with VCP-IS-Na, the maximum concentration of vitamin C in NHDF and NB1RGB cells was 59 and 40 nmol, respectively, and on day 7, the level was the same as that on the first day (Fig. 7) . On the other hand, in the presence of vitamin C and VCP-Na, the amount of vitamin C in normal human fibroblasts was at a maximum on the first day of treat- The NHDFs (A) were incubated with Medium 106S, 50 mM samples and phosphatase inhibitor cocktail II (PIC II). The NB1RGBs (B) were incubated with Dulbecco's modified Eagle's medium (DMEM), 50 mM samples and PIC II. The cells were incubated for 72 h at 37°C in an atmosphere of 5% CO 2 -air. Collagen content was measured by amount of procollagen type I pN-peptide in the supernatant after incubation. Each value represents the meanϮS.D. of five experiments, and values containing asterisks are significantly different from the noninhibition group (Cont.) at pϽ0.05 (*) and pϽ0.01 (**). ment, and decreased rapidly thereafter. In the presence of phosphatase inhibitor, VCP-IS-2Na and VCP-Na decreased the amount of vitamin C in fibroblasts in a manner independent of the dose of phosphatase inhibitor. In the presence of 0.10% PIC II, VCP-IS-2Na decreased vitamin C by 77 and 70% in NHDF and NB1RGB cells, respectively. VCP-Na decreased vitamin C by 58 and 68% in NHDF and NB1RGB cells, respectively, whereas vitamin C had no effect.
DISCUSSION
The present study demonstrated that the novel amphiphilic vitamin C derivative VCP-IS-2Na promoted fibroblast proliferation and type I collagen synthesis, and that these actions were sustained much longer than those with vitamin C and VCP-Na, and that VCP-IS-2Na inhibited MMP-1 activity in normal human fibroblasts. VCP-IS-2Na significantly stimulated type I collagen synthesis in human fibroblasts (Fig. 3) . On the other hand, VCP-IS-2Na slightly inhibited MMP-1 activity in normal human fibroblasts (Fig. 6) . These results indicated that the stimulation of collagen synthesis by VCP-IS-2Na was not due only to the inhibition of MMP-1 activity in normal human fibroblasts. Differences in the promotion of cell proliferation and collagen synthesis and the inhibitory effects were shown between normal human fibroblasts, NHDF and NB1RGB cells. NHDF and NB1RGB cells were shown to have different amounts of intracellular vitamin C. These results may have been due to differences in the cytological characteristics of NHDF and NB1RGB cells.
VCP-IS-2Na was superior to vitamin C and VCP-Na for the promotion of type I collagen synthesis. The promoting effect of VCP-IS-2Na was about six-fold greater than that of vitamin C after 72 h incubation. This is because vitamin C was easily oxidized to dihydroascorbic acid in the culture medium, and did not remain in the medium after 7 d at 37°C (data not shown). On the other hand, VCP-Na and VCP-IS-2Na were relatively stable, and remained in the culture medium after 7 d at 37°C. The promoting effect of VCP-IS2Na was about four-fold greater than that of VCP-Na in normal human fibroblasts after 72 h incubation. The rigid lipid lamella structure of the stratum works as a barrier, especially for the adsorption of hydrophilic compounds. 27 ) Also, we The NHDFs (A) were incubated with Medium 106S, 50 mM samples and phosphatase inhibitor cocktail II (PIC II). The NB1RGBs (B) were incubated with Dulbecco's modified Eagle's medium (DMEM), 50 mM samples and PIC II. The cells were incubated for 1-7 d at 37°C in an atmosphere of 5% CO 2 -air. After a fixed period of time, the cell suspension (1.0ϫ10 7 cells/ml) in PBS was sonicated and centrifuged at 4000 rpm (4°C) for 10 min to obtain a supernatant. The supernatant was determined by HPLC analysis. Each value represents the meanϮS.D. of three experiments.
have already shown that the amount of vitamin C in normal human fibroblasts after 1-7 d incubation with VCP-IS-2Na was twofold greater than that with vitamin C and VCP-Na (Fig. 7) . In the case of vitamin C and VCP-Na, the amount of vitamin C was at a maximum on the first day of culture. However, it decreased thereafter. For VCP-IS-2Na, the amount of vitamin C was maintained at virtually the same level from days 1 to 7 of culture. These results suggested that the difference in the promotion of collagen synthesis by VCP-Na and VCP-IS-2Na in normal human fibroblasts was due to their permeation and vitamin C activity.
These results suggest that VCP-Na is gradually hydrolyzed to vitamin C by phosphatase in normal human fibroblasts, and that vitamin C is unstable and disappears within a short period of time in the culture medium. VCP-IS-2Na is hydrolyzed by tissue esterase and/or phosphatase within a short time, and it is assumed that vitamin C remains for a longer period. Thus, when the promotion of collagen synthesis was studied in prolonged culture, vitamin C and VCP-Na were found to be effective for 3 d, but after that, the amount of collagen synthesis dropped off rapidly (Fig. 4) . In contrast, the promotion of collagen synthesis by VCP-IS-2Na was sustained, and it was still effective for 7 d. This promoting effect of VCP-IS-2Na on collagen synthesis tended to closely follow the amount of vitamin C, strongly suggesting that the VCP-IS-2Na promotion of collagen synthesis arises from the action of vitamin C derived from VCP-IS-2Na through hydrolysis by tissue esterase and/or phosphatase. The enhancing effect of VCP-IS-2Na on the type I collagen production was abrogated in the presence of the phosphatase inhibitor (Fig. 5) .
VCP-Na does not directly act as a cofactor for hydroxylation of proline and lysine residues in procollagen molecules, but it is dephosphorylated on the cell membrane and incorporated as vitamin C. 14, 15) The presence of VCP-IS-2Na in cultured normal human fibroblasts could not be confirmed, but instead, the intercellular amount of vitamin C was observed to increase. Therefore, to exhibit vitamin C activity, VCP-IS-2Na needs to be hydrolyzed before membrane transport. In fact, addition of phosphatase inhibitor to the culture medium completely abolished the promoting effect of VCP-IS-2Na. These results show that the esterase and/or phosphatase bound to cell membranes in normal human fibroblasts, and were involved in the hydrolysis of VCP-IS-2Na.
In conclusion, the novel amphiphilic vitamin C derivative VCP-IS-2Na improved stability compared to VCP-Na, and promoted type I collagen synthesis in normal human skin fibroblasts, and these effects were quickly established and sustained over a long period of time. VCP-IS-2Na slightly inhibited MMP-1 activity in normal human fibroblasts, although stimulation of collagen production by VCP-IS-2Na was not due only to inhibition of MMP-1 production. These effects of VCP-IS-2Na were caused by released vitamin C, through esterase and/or phosphatase hydrolysis in normal human fibroblasts. All effects of VCP-IS-2Na found here were superior to those of VC and VCP-Na by the excellent intercellular VC activity of VCP-IS-2Na. Type I collagen and MMP-1 are important factors in the process of wrinkle formation, which is a common phenomenon of aged skin. Therefore, these findings indicate that VCP-IS-2Na can be used as an antiaging agent for the effective supply of vitamin C with transdermal activity in skin care. We expect that VCP-IS-2Na is utilized not only in the cosmetic field, but also in the production of several useful substances in human cells.
